financetom
UG
financetom
/
Consumer Staples
/
UG
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
United-Guardian, Inc.UG
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
38.18M
Revenue (ttm)
11.41M
Net Income (ttm)
2.89M
Shares Out
4.59M
EPS (ttm)
0.63
PE Ratio
13.23
Forward PE
n/a
Dividend
$0.70 (8.42%)
Ex-Dividend Date
Feb 10, 2025
Volume
6,423
Open
8.14
Previous Close
8.13
Day's Range
8.14 - 8.50
52-Week Range
7.73 - 16.25
Beta
0.92
Analysts
n/a
Price Target
n/a
Earnings Date
Aug 8, 2025
Description >

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.

Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products.

The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology.

Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser.

The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.

Latest News >
L3Harris Technologies Earnings, Revenue Rise; Full-Year Guidance Increased
L3Harris Technologies Earnings, Revenue Rise; Full-Year Guidance Increased
Jul 25, 2024
04:24 PM EDT, 07/25/2024 (MT Newswires) -- L3Harris Technologies ( LHX ) reported Q2 non-GAAP diluted earnings Thursday of $3.24 per share, up from $2.97 a year earlier. Analysts polled by Capital IQ expected $3.18. Revenue for the quarter ended June 30 was $5.30 billion, up from $4.69 billion a year earlier. Analysts surveyed by Capital IQ expected $5.31 billion....
Liberty Global Swings to Q2 Earnings, Revenue Increases
Liberty Global Swings to Q2 Earnings, Revenue Increases
Jul 25, 2024
04:27 PM EDT, 07/25/2024 (MT Newswires) -- Liberty Global ( LBTYA ) reported Q2 earnings late Thursday of $0.71 per diluted share, compared with a loss of $1.13 per share a year earlier. Three analysts polled by Capital IQ expected a loss of $0.73. Revenue for the quarter ended June 30 was $1.87 billion, up from $1.85 billion a year...
Devastating wildfire burns down part of western Canadian tourist town
Devastating wildfire burns down part of western Canadian tourist town
Jul 25, 2024
July 25 (Reuters) - A raging wildfire has devastated the western Canadian tourist town of Jasper, potentially destroying up to 50% of structures, and firefighters were working on Thursday to save as many buildings as possible, authorities said. Jasper is in the middle of mountainous Jasper National Park, in the province of Alberta. The town and the park, which draw...
Cincinnati Financial Q2 Non-GAAP Earnings Rise, Revenue Declines
Cincinnati Financial Q2 Non-GAAP Earnings Rise, Revenue Declines
Jul 25, 2024
04:24 PM EDT, 07/25/2024 (MT Newswires) -- Cincinnati Financial ( CINF ) reported Q2 non-GAAP operating earnings late Thursday of $1.29 per diluted share, up from $1.21 a year earlier. Analysts surveyed by Capital IQ expected $0.96. Revenue for the quarter ended June 30 was $2.54 billion, down from $2.61 billion a year earlier. Four analysts surveyed by Capital IQ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved